ERBB2 and breast cancer: However, positive receptor expression reverted to negative in 19%, 31%, and 28% of organoids for ER, PR, and HER2, respectively.<h4>Conclusion</h4>Breast cancer organoids were successfully established from primary tumor samples, demonstrating good overall concordance in receptor expression with the original tumors.